In pancreatic cancer, MEP1A levels have been reported to significantly increase in the urine of patients with PDACs compared to that with chronic pancreatitis, and its expression has been associated with angiogenesis.22 The gene discussed is MEP1A; the disease is pancreatic neoplasm.